CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a deadly neurological disease with a complicated and variable pathophysiology yet to be fully understood. There is currently no effective treatment available to either slow or terminate it. However, recent advances in ALS genomics have linked genes to phenotype...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yajun, Zhao, Yan, Lu, Likui, Gao, Qinqin, Yu, Dongyi, Sun, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359984/
https://www.ncbi.nlm.nih.gov/pubmed/37483353
http://dx.doi.org/10.3389/fnins.2023.1223777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359984/
https://www.ncbi.nlm.nih.gov/pubmed/37483353
http://dx.doi.org/10.3389/fnins.2023.1223777

Ejemplares similares